Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US7655689B2 · kind B2 · utility
0Cited by
120References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 20, 2006 |
| Grant date | Feb 2, 2010 |
| Priority date | — |
| Expiry date | Jul 19, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.